Fukuoka M - Search Results

1

Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.

Yamamoto N, Tamura T, Fukuoka M, Saijo N. Yamamoto N, et al. Among authors: fukuoka m. Int J Oncol. 1999 Oct;15(4):737-41. Int J Oncol. 1999. PMID: 10493956

2

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S, Masuda N, et al. Fukuoka M, et al. J Clin Oncol. 1992 Jan;10(1):16-20. doi: 10.1200/JCO.1992.10.1.16. J Clin Oncol. 1992. PMID: 1309380 Clinical Trial.

3

Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study.

Fukuoka M, Negoro S, Masuda N, Kusunoki Y, Matsui K, Ryu S, Takifuji N, Kudoh S, Takada M. Fukuoka M, et al. Am J Clin Oncol. 1992 Feb;15(1):18-22. doi: 10.1097/00000421-199202000-00004. Am J Clin Oncol. 1992. PMID: 1312768 Clinical Trial.

4

[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].

Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, Yamaguchi Y. Furuse K, et al. Among authors: fukuoka m. Gan To Kagaku Ryoho. 1992 Jul;19(7):1019-26. Gan To Kagaku Ryoho. 1992. PMID: 1320846 Clinical Trial. Japanese.

5

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

Masuda N, Fukuoka M, Kusunoki Y, Matsui K, Takifuji N, Kudoh S, Negoro S, Nishioka M, Nakagawa K, Takada M. Masuda N, et al. Among authors: fukuoka m. J Clin Oncol. 1992 Aug;10(8):1225-9. doi: 10.1200/JCO.1992.10.8.1225. J Clin Oncol. 1992. PMID: 1321891 Clinical Trial.

6

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.

Masuda N, Fukuoka M, Takada M, Kusunoki Y, Negoro S, Matsui K, Kudoh S, Takifuji N, Nakagawa K, Kishimoto S. Masuda N, et al. Among authors: fukuoka m. J Clin Oncol. 1992 Nov;10(11):1775-80. doi: 10.1200/JCO.1992.10.11.1775. J Clin Oncol. 1992. PMID: 1328551

7

Weekly dose-intensive chemotherapy in patients with small-cell lung cancer: a pilot study.

Kudoh S, Fukuoka M, Negoro S, Tanaka H, Kusunoki Y, Matsui K, Masuda N, Takifugi N, Itoh K, Nishioka M, et al. Kudoh S, et al. Among authors: fukuoka m. Am J Clin Oncol. 1992 Feb;15(1):29-34. doi: 10.1097/00000421-199202000-00006. Am J Clin Oncol. 1992. PMID: 1372463

8

CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small cell lung cancer.

Masuda N, Fukuoka M, Furuse K. Masuda N, et al. Among authors: fukuoka m. Oncology. 1992;49 Suppl 1:19-24. doi: 10.1159/000227106. Oncology. 1992. PMID: 1380148 Clinical Trial.

9

Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer.

Fukuoka M, Furuse K, Saijo N, Nishiwaki Y, Ikegami H, Tamura T, Shimoyama M, Suemasu K. Fukuoka M, et al. J Natl Cancer Inst. 1991 Jun 19;83(12):855-61. doi: 10.1093/jnci/83.12.855. J Natl Cancer Inst. 1991. PMID: 1648142 Clinical Trial.

10

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.

Fukuoka M, Masuda N, Furuse K, Negoro S, Takada M, Matsui K, Takifuji N, Kudoh S, Kawahara M, Ogawara M, et al. Fukuoka M, et al. J Clin Oncol. 1991 Apr;9(4):606-13. doi: 10.1200/JCO.1991.9.4.606. J Clin Oncol. 1991. PMID: 1648597 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters